Victoria P. Werth - Faculty Biosketch

Victoria P. Werth, M.D.

Professor of Dermatology at the Hospital of the University of Pennsylvania and the Veteran's Administration Medical Center

Department: Dermatology

Contact information

Division of Dermatology
Veterans Administration Hospital
University and Woodland Avenues
Philadelphia, PA 19104

Office: 215-823-4208
Fax: 215-823-5171

Education:
MS (Physical Chemistry)
Catholic University, 1976.
BA (Chemistry)
Catholic University, 1976.
M.D. (Medicine)
Johns Hopkins University, 1980.

Links
Lupus Research Institute
Pennsylvania Academy of Dermatology
Philadelphia Dermatology Society
Scleroderma Foundation
The Myositis Association
Lupus Foundation of America
International Pemphigus and Pemphigoid Foundation
Medical Dermatology Society

Post-Graduate Training
Intern in Medicine, Northwestern Memorial Hospital, Chicago, 1980-1981.
Resident in Internal Medicine, Northwestern Memorial Hospital, Chicago, 1981-1983.
Resident in Dermatology, New York University, 1983-1986.
Chief Resident in Dermatology, New York University, 1985-1986.
Research Fellow in Dermatology, New York University, 1986-1988.
Dermatology Foundation Fellow, New York University, 1987-1989.

Certifications
American Board of Internal Medicine, 1983.
American Board of Dermatology, 1986.
American Boards of Immunodermatology and Immunopathology, 1989.

Permanent link

> Perelman School of Medicine > Faculty > Details

Description of Research Expertise

Photobiology
Tumor necrosis factor
Cutaneous lupus
Glycosaminoglycans
Clinical and translational research in cutaneous autoimmune diseases

Description of Clinical Expertise

Autoimmune skin disease
Cutaneous Lupus Erythematosus
Dermatomyositis
Pemphigus vulgaris

Selected Publications

Dan J, Afarideh M , Sprow G Keyes E, Diaz D, Vazquez T, Kodali N, Werth VP.: Preliminary definition od cutaeous flare in dermatomyositis: a retrospective review. J Am Acad Dermatol 2023 Notes: 88(1):190-191.

Sprow G, Afarideh M, Dan J, Hedberg ML, Werth VP.: Bullous systemic lupus erythematosus in females. International Journal of Women's Dermatology October 2022 Notes: 8(3)-p e034 doi:10.1097/JW9.0000000000000034.

Sprow G, Dan J, Merola JF, Werth VP. : Emerging therapies in cutaneous lupus erythematosus. Front Med (Lausanne). July 2022 Notes: 11;9:968323.doi:10.3389/fmed.2022.968323.PMID:35899214;PMCID:PMC9313535.

Ujiie H, Rosmarine D, Schon MP, Stander S, Boch K, Matz M, Maurer M, Thaci D, Schmidt E, Cole C, Amber KT, Didona D, Hertl M, Recke A, Grabhoff H, Hackel A, Schumann A, Riemekasten G, Bieber K, Sprow G, Dan J, Zillikens D, Sezin T, Christiano AM, Wolk K, Sabat R, Kridin K, Werth VP, Ludwig RJ.: Unmet medical needs in chronic, non-communicable inflammatory skin diseases. Front Med (Lausanne) June 2022 Notes: 9;9:875492.doi:10.3389/fmed.2022.875492.PMID:35755063;PMCID:PMC9218547.

Sprow G, Dan J, Abbott J, Jiang A, Diaz D, Vazquez T, Kodali N, Werth VP. : Sclerotic skin disease development following COVID-19 vaccination. JAAD Case Rep. April 2022 Notes: 22:74-77.

Raavishankar A, Bax CE, Grinnell M, Yan D, Conha JS, Pappas-Taaffer L, Shields BE, Dany M, Clark AK, Feng R, Okawa J, Werth VP.: Frequency of immunostimulatory herbal supplement use amound patients with autoimmune skin disease. J Am Acad Dermatol January 2022 Notes: S01190-9622(22)00012-3.doi:10.1016/j.jaad.2021.12.050.

Furie R, Hough D, Gaudy A, Ye Y, Korish S, Delev N, Weiswasser M, Zhan, Schafer P, Werth V.: Iberdomide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled, ascending-dose, phase 2a study Lupus Science & Medicine Lupus 9:e000581, 2022 Notes: doi: 10.1136/lupus-2021-000581.

Sprow G, Dan J, Feng R, Werth VP.: Comparing dermatologic patient-reported outcome measures in cutaneous lupus erythematosus. Lupus Science & Medicine 2022 Notes: 9:e000827.doi:10.1136/lupus-2022-000827.

Patel J, Vazquez T, Chin F, Keyes E, Yan D, Diaz D, Grinnell M, Sharma M, Li Y, Feng R, Sprow G, Dan J, Werth VP.: Multidimensional immune profiling of cutaneous lupus erythematosus in vivo stratified by patient respinses to antimalarials. Arthritis Rheumatol 2022 Notes: https://doi.org/10.1002/art.42235.

Furie RA, Van Vollenhoven RF, Kalunian K, Navarra S, Romero-Diaz J, Werth VP Huang X, Clark G, Carroll C, Meyers A, Musselli C, Barbey C, Franchimont N. : For the LILAC trail investigators. N Engl J Med 2022 Notes: 387:894-904.